Il Ung Oh

Il Ung Oh

Auto-generated profile, based on publicly available information

Il Ung Oh

Organoid Standards Initiative

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2024 in International Journal of Stem Cells
Verified
Journal Article
Open access
PDF file
SASun-Ju Ahn
Sun-Ju Ahn
SLSungin Lee
Sungin Lee
DKDayeon Kwon
Dayeon Kwon
SOSejeong Oh
Sejeong Oh
CPChihye Park
Chihye Park
IOIl Ung Oh
Il Ung Oh
Sun-Ju Ahn, Sungin Lee, Dayeon Kwon, Sejeong Oh, Chihye Park, Sooyeon Jeon, Jin Hee Lee, Tae Sung Kim, Il Ung Oh. IJSC -0001;0:. https://doi.org/10.15283/ijsc24047

17 May 2024 in Toxics
Verified
Journal Article
Open access
PDF file
SCSeo Yoon Choi
Seo Yoon Choi
TKTae Hee Kim
Tae Hee Kim
MKMin Jeong Kim
Min Jeong Kim
SMSeon Ju Mun
Seon Ju Mun
TKTae Sung Kim
Tae Sung Kim
JLJin Hee Lee
Jin Hee Lee
“Organoids”, three-dimensional self-organized organ-like miniature tissues, are proposed as intermediary models that bridge the gap between animal and human studies in drug development. Despite recent advancements in organoid model development, studies on toxicity using these models are limited. Therefore, in this study, we aimed to analyze the functionality and gene expression of pre- and post-differentiated human hepatic organoids derived from induced pluripotent stem cells and utilize them for toxicity assessment. First, we confirmed the functional similarity of this hepatic organoid model to the human liver through various functional assessments, such as glycogen storage, albumin and bile acid secretion, and cytochrome P450 (CYP) activity. Subsequently, utilizing these functionally validated hepatic organoids, we conducted toxicity evaluations with three hepatotoxic substances (ketoconazole, troglitazone, and tolcapone), which are well known for causing drug-induced liver injury, and three non-hepatotoxic substances (sucrose, ascorbic acid, and biotin). The organoids effectively distinguished between the toxicity levels of substances with and without hepatic toxicity. We demonstrated the potential of hepatic organoids with validated functionalities and genetic characteristics as promising models for toxicity evaluation by analyzing toxicological changes occurring in hepatoxic drug-treated organoids.

13 May 2024 in International Journal of Stem Cells
Verified
Journal Article
Open access
PDF file
SLSungin Lee
Sungin Lee
DKDayeon Kwon
Dayeon Kwon
HLHan Byeol Lee
Han Byeol Lee
SJSooyeon Jeon
Sooyeon Jeon
CPChihye Park
Chihye Park
SASun-Ju Ahn
Sun-Ju Ahn
Sungin Lee, Dayeon Kwon, Han Byeol Lee, Sooyeon Jeon, Chihye Park, Tae Sung Kim, Jin Hee Lee, Il Ung Oh, Sun-Ju Ahn. IJSC 2024;17:113-9. https://doi.org/10.15283/ijsc24042